Affidea Enters Into An Agreement To Acquire Medeuropa Romania

By Author: Orson Amiri
Total Articles: 401
Comment this article

Affidea Group, Europe's largest provider of advanced diagnostics, is set to acquire MedEuropa Romania, a prominent cancer care provider, in a binding agreement. MedEuropa Romania operates four medical centers across the country, known for their expertise in advanced cancer care, including Radiotherapy, Chemotherapy, and broader oncology services. The acquisition will integrate MedEuropa's services into Affidea's existing diagnostic and polyclinic portfolio in Romania, enhancing its capabilities and adding radiotherapy services. This move addresses the significant impact of cancer in Romania, with around 100,000 people diagnosed annually. Affidea aims to stand alongside the National Health System, working towards comprehensive cancer care pathways from diagnosis to treatment and follow-up, ultimately improving outcomes for patients.

Razvan Predica, Country CEO for Affidea Romania and Hungary, highlights the acquisition's importance in addressing the high incidence of cancer in the country and expresses the commitment to collaborate with MedEuropa to enhance access to comprehensive cancer care. Guy Blomfield, CEO and Chairman ...
... of the Management Board for Affidea Group, emphasizes the potential for improving early detection, diagnosis, and radiotherapy services across Romania through their integrated service model. The completion of the acquisition is pending approval from the Romanian Competition Council. Affidea Group was advised by Rizoiu & Asociatii and Clifford Chance, with Deloitte serving as a financial advisor, while the sellers were advised by Biris Goran and Linklaters.

Read More - https://www.techdogs.com/tech-news/pr-newswire/affidea-enters-into-an-agreement-to-acquire-medeuropa-romania